SlideShare a Scribd company logo
1 of 1
Download to read offline
A Comparison of In-hospital Myocardial Infarction Management
Between Portugal and the United States | 2000 – 2010
Lobo MF • Azzone V • Azevedo LF • Teixeira-Pinto A • Pereira-Miguel J • Costa-Pereira A • Resnic F • Normand SLT
What is Known
Data Sources
// Inter- & intra-country variability in new medical technology
diffusion exist
// International comparative studies provide an opportunity
to assess technology effectiveness
Population & Statistical Approach Age-Sex Standardize AMI Hospitalizations
Rates and 95% CI
Adults >19 with AMI
Age-Sex Standardize In-Hospital Mortality
Rates and 95% CI
2010, Adults >19 with AMIPOPULATION:
// Adults (> 19 yrs) inpatient discharged with a new AMI
between Jan. 1, 2000 and Dec. 31, 2010
// Both patients discharged to hospice or left against medical
advice and invalid discharges were excluded
STATISTICAL APPROACH
// ICD-9-CM codes identified new AMI (410.x, no 410.x2)
admissions and in-hospital procedures; discharge status (alive
vs dead); and length of stay
// Cohorts stratified by STEMI (410.0-410.6, 410.8) and
Non-STEMI (410.7, 410.9) status
// Intra & inter-country age-sex standardized rates of AMI
hospitalizations, procedures and mortality
// There is an increasing AMI hospital admission rate in Portugal
over the past decade that contrasts with a decreasing rate
in the U.S.
// Utilization of in-hospital cardiac surgical procedures differs
between the two countries, with the U.S. generally having
higher use
// Coronary artery bypass grafting surgery after AMI is surprisingly
low in Portugal
// The differences in procedure utilization, length of hospital
stay, or a combination of these factors may explain the
higher in-hospital mortality rate after a heart attack in
Portugal compared to the U.S.
// U.S.: HCUP 20% inpatient sample
// Portugal: ACSS 100% inpatient data from public
sector hospitals*
// Equivalent key variables in the two datasets:
/ Demographic information
/ Diagnosis and procedure codes classification (ICD-9-CM)
/ Principal diagnosis
// Differences in the datasets:
/ Different number of codes
/ No race information in PT
/ Discharge status categorical values
/ Billing information (Charges/DRGs)
// 2010 population census information
Abbv. HCUP – Health Cost and Utilization Project; ACSS – Administração Central do
Sistema de Saúde; ICD-9-CM – International Classification of Diseases, 9th
Revision, Clinical Modification. DRG – Diagnosis-Related Group
*Corresponds to 84% of all inpatient discharges in Portugal (2000-2010)
To compare trends in in-hospital AMI
treatment & outcomes between U.S.
and Portugal
Aim
Country U.S. Portugal
Year 2000 2010 2000 2010
# Discharges 145,185 114,915 9,021 12,037
# Hospitals 932 916 76 51
Male, % 59 61 68 65
Mean Age [SD]
Risk Factors/
Comorbidities, %
68 [14] 67 [14] 67 [13] 69 [14]
% Aged ≥ 80 24 24 14 22
Diabetes 2.8 2.8 1.3 3.3
Hypertension 45 64 32 53
PVD 7.7 11 2.2 4.4
Renal Failure 8.9 17 5.3 4.2
COPD 16 16 3.9 4.4
VHD 11 11 6.3 12
Median Length of
Stay, [IQR] days
5 [3,8] 4 [3,7] 9 [6,13] 7 [5,10]
Survivors 5 [3,8] 4 [3,7] 10 [7,13 ] 7 [5,10]
Non-Survivors 4 [2,8] 4 [2,7] 3 [2,7] 3 [2,8]
† Standardized to 2010 US
Country U.S. Portugal Portugal/U.S.
In-Hospital
Procedures
Crude rates, %
2010
Standardized
RateRatio†
Year
Cath
CABG Surgery
Off Pump
PCI
Stenting
Revascularization
OtherHeart Proc.
0.87 [0.75,1.00]
0.19 [0.14, 0.26]
0.38 [0.26, 0.54]
1.07 [0.93,1.24]
0.95 [0.86, 1.04]
0.97 [0.85,1.12]
1.16 [0.80,1.67]
Rateper1000Population
All AMIs STEMI NSTEMI
020406080100120
29.1 62.1 40.1 77 29.4 41.4
All AMI STEMI NSTEMI
Crude
rates, %
N
Crude
rates, %
N
Crude
rates, %
N
U. S. 53.0 6,087 63.6 2,066 48.8 4,021
Portugal 94.9 1,142 105.4 635 84.3 507
Standardized to 2010 U.S. Population
Disclosures: Nothing to disclose. Funded by FCT, QREN, COMPETE (HMSP-ICT/0013/2011)
What this Study Adds
Disclosures: Nothing to disclose. Funded by FCT, QREN, COMPETE (HMSP-ICT/0013/2011)
2000 2002 2004 2006 2008 2010
Discharge Year (Standardized to 2010 US Population)
RatePer1000Population
04812162024
All AMI
STEMI
NSTEMI
All AMI
STEMI
NSTEMI
United States
Portugal
Shading represents
95% confidence bands
www.cuteheart.com
marianalobo@med.up.pt
United States
Portugal
Error bar represents
95% confidence bands

More Related Content

What's hot

American Journal of Urology Research
American Journal of Urology ResearchAmerican Journal of Urology Research
American Journal of Urology Research
SciRes Literature LLC. | Open Access Journals
 
632 0713 - ferreyro bl - predictive score for estimating cancer after venou...
632   0713 - ferreyro bl - predictive score for estimating cancer after venou...632   0713 - ferreyro bl - predictive score for estimating cancer after venou...
632 0713 - ferreyro bl - predictive score for estimating cancer after venou...
Debourdeau Phil
 
Heart Failure - large market opportunities for new biomarkers
Heart Failure - large market opportunities for new biomarkersHeart Failure - large market opportunities for new biomarkers
Heart Failure - large market opportunities for new biomarkers
Winton Gibbons
 
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
Dr Tarique Ahmed Maka
 
POSTER Group18 Predicting pancreatic cancer_finalversion
POSTER Group18 Predicting pancreatic cancer_finalversionPOSTER Group18 Predicting pancreatic cancer_finalversion
POSTER Group18 Predicting pancreatic cancer_finalversion
Zidi Xiu
 

What's hot (20)

Liver Stiffness Evaluation in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
Liver Stiffness Evaluation  in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.Liver Stiffness Evaluation  in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
Liver Stiffness Evaluation in DM Type 2, Ng t Hồng Anh- Ng Thiện Hùng.
 
Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma (HCC)
 
American Journal of Urology Research
American Journal of Urology ResearchAmerican Journal of Urology Research
American Journal of Urology Research
 
1606471580
16064715801606471580
1606471580
 
Data mining visualization to support biochemical markers for liver fibrosis i...
Data mining visualization to support biochemical markers for liver fibrosis i...Data mining visualization to support biochemical markers for liver fibrosis i...
Data mining visualization to support biochemical markers for liver fibrosis i...
 
Extracorporeal Photopheresis in Sézary Syndrome
Extracorporeal Photopheresis in Sézary Syndrome Extracorporeal Photopheresis in Sézary Syndrome
Extracorporeal Photopheresis in Sézary Syndrome
 
Prieditis steatosis bcr10
Prieditis steatosis bcr10Prieditis steatosis bcr10
Prieditis steatosis bcr10
 
Article_FCR
Article_FCRArticle_FCR
Article_FCR
 
632 0713 - ferreyro bl - predictive score for estimating cancer after venou...
632   0713 - ferreyro bl - predictive score for estimating cancer after venou...632   0713 - ferreyro bl - predictive score for estimating cancer after venou...
632 0713 - ferreyro bl - predictive score for estimating cancer after venou...
 
De corteetal2016
De corteetal2016De corteetal2016
De corteetal2016
 
Journal club
Journal clubJournal club
Journal club
 
Heart Failure - large market opportunities for new biomarkers
Heart Failure - large market opportunities for new biomarkersHeart Failure - large market opportunities for new biomarkers
Heart Failure - large market opportunities for new biomarkers
 
Causes of death in hiv 1-infected patients 2010
Causes of death in hiv 1-infected patients 2010Causes of death in hiv 1-infected patients 2010
Causes of death in hiv 1-infected patients 2010
 
WCIM poster 2016, Bali
WCIM poster 2016, BaliWCIM poster 2016, Bali
WCIM poster 2016, Bali
 
Open Journal of Surgery
Open Journal of SurgeryOpen Journal of Surgery
Open Journal of Surgery
 
Prognostic parameters in adrenocortical carcinoma | Γιώργος Ζωγράφος - Γιατ...
Prognostic parameters in adrenocortical carcinoma | Γιώργος Ζωγράφος - Γιατ...Prognostic parameters in adrenocortical carcinoma | Γιώργος Ζωγράφος - Γιατ...
Prognostic parameters in adrenocortical carcinoma | Γιώργος Ζωγράφος - Γιατ...
 
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
 
POSTER Group18 Predicting pancreatic cancer_finalversion
POSTER Group18 Predicting pancreatic cancer_finalversionPOSTER Group18 Predicting pancreatic cancer_finalversion
POSTER Group18 Predicting pancreatic cancer_finalversion
 
Does Mitral Valve Commissural Calcification Predicts Restenosis at Long-Term ...
Does Mitral Valve Commissural Calcification Predicts Restenosis at Long-Term ...Does Mitral Valve Commissural Calcification Predicts Restenosis at Long-Term ...
Does Mitral Valve Commissural Calcification Predicts Restenosis at Long-Term ...
 
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
 

Similar to Poster 2 presented at QCOR Baltimore 2014 MLobo

2019 AHA Hypertension Management in Older and Frail Older Patients.pdf
2019 AHA Hypertension Management in Older and Frail Older Patients.pdf2019 AHA Hypertension Management in Older and Frail Older Patients.pdf
2019 AHA Hypertension Management in Older and Frail Older Patients.pdf
karimahkhitamiaziz1
 
Preliminary assessment of adherence to 1st tier health
Preliminary assessment of adherence to 1st tier healthPreliminary assessment of adherence to 1st tier health
Preliminary assessment of adherence to 1st tier health
lrogers75
 
Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
Late Outcomes of Cord Blood Transplantation for Patients with Hurler SyndromeLate Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
cordbloodsymposium
 
Efficacy and accuracy of quick sepsis-related organ failure assessment (qSOFA...
Efficacy and accuracy of quick sepsis-related organ failure assessment (qSOFA...Efficacy and accuracy of quick sepsis-related organ failure assessment (qSOFA...
Efficacy and accuracy of quick sepsis-related organ failure assessment (qSOFA...
ErnestDMenace
 
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Erwin Chiquete, MD, PhD
 
Journal Reading ACS Regis Kupang.pptx
Journal Reading ACS Regis Kupang.pptxJournal Reading ACS Regis Kupang.pptx
Journal Reading ACS Regis Kupang.pptx
WELCINOVIDA1
 
Stm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refsStm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refs
monkmartinez
 

Similar to Poster 2 presented at QCOR Baltimore 2014 MLobo (20)

Poster 1 presented at QCOR Baltimore 2014 MLobo
Poster 1 presented at QCOR Baltimore 2014 MLoboPoster 1 presented at QCOR Baltimore 2014 MLobo
Poster 1 presented at QCOR Baltimore 2014 MLobo
 
8381.ppt
8381.ppt8381.ppt
8381.ppt
 
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, InvestmentPoint of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
 
2019 AHA Hypertension Management in Older and Frail Older Patients.pdf
2019 AHA Hypertension Management in Older and Frail Older Patients.pdf2019 AHA Hypertension Management in Older and Frail Older Patients.pdf
2019 AHA Hypertension Management in Older and Frail Older Patients.pdf
 
Preliminary assessment of adherence to 1st tier health
Preliminary assessment of adherence to 1st tier healthPreliminary assessment of adherence to 1st tier health
Preliminary assessment of adherence to 1st tier health
 
M EAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE...
M EAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE...M EAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE...
M EAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE...
 
And the winner is... smart doctors
And the winner is... smart doctorsAnd the winner is... smart doctors
And the winner is... smart doctors
 
Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
Late Outcomes of Cord Blood Transplantation for Patients with Hurler SyndromeLate Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
 
Efficacy and accuracy of quick sepsis-related organ failure assessment (qSOFA...
Efficacy and accuracy of quick sepsis-related organ failure assessment (qSOFA...Efficacy and accuracy of quick sepsis-related organ failure assessment (qSOFA...
Efficacy and accuracy of quick sepsis-related organ failure assessment (qSOFA...
 
DU PERF AND ABX
DU PERF AND ABX DU PERF AND ABX
DU PERF AND ABX
 
The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials The use of mobile solutions in cardiovascular disease trials
The use of mobile solutions in cardiovascular disease trials
 
HTAI 2015 - Bariatric surgery impact on healthcare utilization in a brazilia...
HTAI 2015 -  Bariatric surgery impact on healthcare utilization in a brazilia...HTAI 2015 -  Bariatric surgery impact on healthcare utilization in a brazilia...
HTAI 2015 - Bariatric surgery impact on healthcare utilization in a brazilia...
 
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a...
 
Long term outcomes in patients with h fr-ef treated with cabg vs pci
Long term outcomes in patients with h fr-ef treated with cabg vs pciLong term outcomes in patients with h fr-ef treated with cabg vs pci
Long term outcomes in patients with h fr-ef treated with cabg vs pci
 
Oncology treatment patterns in the South Island
Oncology treatment patterns in the South IslandOncology treatment patterns in the South Island
Oncology treatment patterns in the South Island
 
GPRD 2010
GPRD 2010GPRD 2010
GPRD 2010
 
Journal Reading ACS Regis Kupang.pptx
Journal Reading ACS Regis Kupang.pptxJournal Reading ACS Regis Kupang.pptx
Journal Reading ACS Regis Kupang.pptx
 
Stm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refsStm functional showdeck mockup v2 w refs
Stm functional showdeck mockup v2 w refs
 
Management of Acute Heart Failure
Management of Acute Heart FailureManagement of Acute Heart Failure
Management of Acute Heart Failure
 
What do we need to indicate CTO PCI?
What do we need to indicate CTO PCI?What do we need to indicate CTO PCI?
What do we need to indicate CTO PCI?
 

More from LBNicolau

More from LBNicolau (17)

Program of the 2nd CUTEHeart Workshop
Program of the 2nd CUTEHeart WorkshopProgram of the 2nd CUTEHeart Workshop
Program of the 2nd CUTEHeart Workshop
 
Program of the 1st CUTEHeart Workshop
Program of the 1st CUTEHeart WorkshopProgram of the 1st CUTEHeart Workshop
Program of the 1st CUTEHeart Workshop
 
CUTEHeart's Poster Session in CPC2016
CUTEHeart's Poster Session in CPC2016CUTEHeart's Poster Session in CPC2016
CUTEHeart's Poster Session in CPC2016
 
CUTEHeart Poster session of CPC2016
CUTEHeart Poster session of CPC2016CUTEHeart Poster session of CPC2016
CUTEHeart Poster session of CPC2016
 
1st CUTEHeart Workshop Evaluation
1st CUTEHeart Workshop Evaluation1st CUTEHeart Workshop Evaluation
1st CUTEHeart Workshop Evaluation
 
2nd CUTEHeart Workshop Conclusions
2nd CUTEHeart Workshop Conclusions2nd CUTEHeart Workshop Conclusions
2nd CUTEHeart Workshop Conclusions
 
2nd CUTEHeart Workshop Manuel Gomes Presentation
2nd CUTEHeart Workshop Manuel Gomes Presentation2nd CUTEHeart Workshop Manuel Gomes Presentation
2nd CUTEHeart Workshop Manuel Gomes Presentation
 
2nd CUTEHeart Workshop Constantine Gatsosis Presentation
2nd CUTEHeart Workshop Constantine Gatsosis Presentation2nd CUTEHeart Workshop Constantine Gatsosis Presentation
2nd CUTEHeart Workshop Constantine Gatsosis Presentation
 
1st CUTEHeart Workshop Horvitz-Lennon Presentation
1st CUTEHeart Workshop Horvitz-Lennon Presentation1st CUTEHeart Workshop Horvitz-Lennon Presentation
1st CUTEHeart Workshop Horvitz-Lennon Presentation
 
1st CUTEHeart Workshop Wyatt Presentation
1st CUTEHeart Workshop Wyatt Presentation1st CUTEHeart Workshop Wyatt Presentation
1st CUTEHeart Workshop Wyatt Presentation
 
1st CUTEHeart Workshop Berger Presentation
1st CUTEHeart Workshop Berger Presentation1st CUTEHeart Workshop Berger Presentation
1st CUTEHeart Workshop Berger Presentation
 
1st CUTEHeart Workshop Resnic Presentation
1st CUTEHeart Workshop Resnic Presentation1st CUTEHeart Workshop Resnic Presentation
1st CUTEHeart Workshop Resnic Presentation
 
Poster presented at ISPOR Vienna 2016 LBacelar-Nicolau
Poster presented at ISPOR Vienna 2016 LBacelar-NicolauPoster presented at ISPOR Vienna 2016 LBacelar-Nicolau
Poster presented at ISPOR Vienna 2016 LBacelar-Nicolau
 
Oral Presentation at ISPOR Portugal 2016 LBacelar-Nicolau
Oral Presentation at ISPOR Portugal 2016 LBacelar-NicolauOral Presentation at ISPOR Portugal 2016 LBacelar-Nicolau
Oral Presentation at ISPOR Portugal 2016 LBacelar-Nicolau
 
Poster presented at ISPOR Milan 2015 MLobo
Poster presented at ISPOR Milan 2015 MLoboPoster presented at ISPOR Milan 2015 MLobo
Poster presented at ISPOR Milan 2015 MLobo
 
Oral Presentation at EUPHA Milan 2015 LBacelar-Nicolau
Oral Presentation at EUPHA Milan 2015 LBacelar-NicolauOral Presentation at EUPHA Milan 2015 LBacelar-Nicolau
Oral Presentation at EUPHA Milan 2015 LBacelar-Nicolau
 
Poster presented at ECE Maastricht 2015 LBacelar-Nicolau
Poster presented at ECE Maastricht 2015 LBacelar-NicolauPoster presented at ECE Maastricht 2015 LBacelar-Nicolau
Poster presented at ECE Maastricht 2015 LBacelar-Nicolau
 

Recently uploaded

An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
SanaAli374401
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 

Recently uploaded (20)

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 

Poster 2 presented at QCOR Baltimore 2014 MLobo

  • 1. A Comparison of In-hospital Myocardial Infarction Management Between Portugal and the United States | 2000 – 2010 Lobo MF • Azzone V • Azevedo LF • Teixeira-Pinto A • Pereira-Miguel J • Costa-Pereira A • Resnic F • Normand SLT What is Known Data Sources // Inter- & intra-country variability in new medical technology diffusion exist // International comparative studies provide an opportunity to assess technology effectiveness Population & Statistical Approach Age-Sex Standardize AMI Hospitalizations Rates and 95% CI Adults >19 with AMI Age-Sex Standardize In-Hospital Mortality Rates and 95% CI 2010, Adults >19 with AMIPOPULATION: // Adults (> 19 yrs) inpatient discharged with a new AMI between Jan. 1, 2000 and Dec. 31, 2010 // Both patients discharged to hospice or left against medical advice and invalid discharges were excluded STATISTICAL APPROACH // ICD-9-CM codes identified new AMI (410.x, no 410.x2) admissions and in-hospital procedures; discharge status (alive vs dead); and length of stay // Cohorts stratified by STEMI (410.0-410.6, 410.8) and Non-STEMI (410.7, 410.9) status // Intra & inter-country age-sex standardized rates of AMI hospitalizations, procedures and mortality // There is an increasing AMI hospital admission rate in Portugal over the past decade that contrasts with a decreasing rate in the U.S. // Utilization of in-hospital cardiac surgical procedures differs between the two countries, with the U.S. generally having higher use // Coronary artery bypass grafting surgery after AMI is surprisingly low in Portugal // The differences in procedure utilization, length of hospital stay, or a combination of these factors may explain the higher in-hospital mortality rate after a heart attack in Portugal compared to the U.S. // U.S.: HCUP 20% inpatient sample // Portugal: ACSS 100% inpatient data from public sector hospitals* // Equivalent key variables in the two datasets: / Demographic information / Diagnosis and procedure codes classification (ICD-9-CM) / Principal diagnosis // Differences in the datasets: / Different number of codes / No race information in PT / Discharge status categorical values / Billing information (Charges/DRGs) // 2010 population census information Abbv. HCUP – Health Cost and Utilization Project; ACSS – Administração Central do Sistema de Saúde; ICD-9-CM – International Classification of Diseases, 9th Revision, Clinical Modification. DRG – Diagnosis-Related Group *Corresponds to 84% of all inpatient discharges in Portugal (2000-2010) To compare trends in in-hospital AMI treatment & outcomes between U.S. and Portugal Aim Country U.S. Portugal Year 2000 2010 2000 2010 # Discharges 145,185 114,915 9,021 12,037 # Hospitals 932 916 76 51 Male, % 59 61 68 65 Mean Age [SD] Risk Factors/ Comorbidities, % 68 [14] 67 [14] 67 [13] 69 [14] % Aged ≥ 80 24 24 14 22 Diabetes 2.8 2.8 1.3 3.3 Hypertension 45 64 32 53 PVD 7.7 11 2.2 4.4 Renal Failure 8.9 17 5.3 4.2 COPD 16 16 3.9 4.4 VHD 11 11 6.3 12 Median Length of Stay, [IQR] days 5 [3,8] 4 [3,7] 9 [6,13] 7 [5,10] Survivors 5 [3,8] 4 [3,7] 10 [7,13 ] 7 [5,10] Non-Survivors 4 [2,8] 4 [2,7] 3 [2,7] 3 [2,8] † Standardized to 2010 US Country U.S. Portugal Portugal/U.S. In-Hospital Procedures Crude rates, % 2010 Standardized RateRatio† Year Cath CABG Surgery Off Pump PCI Stenting Revascularization OtherHeart Proc. 0.87 [0.75,1.00] 0.19 [0.14, 0.26] 0.38 [0.26, 0.54] 1.07 [0.93,1.24] 0.95 [0.86, 1.04] 0.97 [0.85,1.12] 1.16 [0.80,1.67] Rateper1000Population All AMIs STEMI NSTEMI 020406080100120 29.1 62.1 40.1 77 29.4 41.4 All AMI STEMI NSTEMI Crude rates, % N Crude rates, % N Crude rates, % N U. S. 53.0 6,087 63.6 2,066 48.8 4,021 Portugal 94.9 1,142 105.4 635 84.3 507 Standardized to 2010 U.S. Population Disclosures: Nothing to disclose. Funded by FCT, QREN, COMPETE (HMSP-ICT/0013/2011) What this Study Adds Disclosures: Nothing to disclose. Funded by FCT, QREN, COMPETE (HMSP-ICT/0013/2011) 2000 2002 2004 2006 2008 2010 Discharge Year (Standardized to 2010 US Population) RatePer1000Population 04812162024 All AMI STEMI NSTEMI All AMI STEMI NSTEMI United States Portugal Shading represents 95% confidence bands www.cuteheart.com marianalobo@med.up.pt United States Portugal Error bar represents 95% confidence bands